Board Meetings for GML

Detailed list of historic and upcoming board meetings.

SymbolCompanyMeeting DatePurposeDescriptionLinks
GMLGalaxy Medicare Limited29 May 2026Financial Results/DividendTo Consider and Approve the Financial Results for the Period Ended March 31, 2026 and Dividend
GMLGalaxy Medicare Limited29 May 2026Board Meeting IntimationGALAXY MEDICARE LIMITED has informed the Exchange about Board Meeting to be held on 29-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend.
GMLGalaxy Medicare Limited10 Dec 2025Financial Results/DividendGML : 10-Dec-2025 : The Company has informed the Exchange that a Board meeting to be held on November 13, 2025 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on December 10, 2025, To consider and approve the financial results for the period ended September 30, 2025 and dividend
GMLGalaxy Medicare Limited10 Dec 2025Board Meeting IntimationGALAXY MEDICARE LIMITED has informed the Exchange about Board Meeting to be held on 10-Dec-2025 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2025 and Dividend.
GMLGalaxy Medicare Limited13 Nov 2025Board Meeting IntimationGALAXY MEDICARE LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2025 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2025 and Dividend.
GMLGalaxy Medicare Limited13 Nov 2025Board meeting RescheduledGalaxy Medicare Limited has informed the Exchange that the meeting of the Board of Directors of the Company scheduled to be held on November 13, 2025 To consider and approve the financial results for the period ended September 30, 2025, dividend and other business matters has been postponed
GMLGalaxy Medicare Limited13 Nov 2025Financial Results/Dividend/Other business mattersTo consider and approve the financial results for the period ended September 30, 2025, dividend and other business matters
Showing page 1 of 1 (7 total items)